原癌基因酪氨酸蛋白激酶受體RET/多發(fā)性內(nèi)分泌腺瘤和甲狀腺髓樣癌蛋白抗體,公司抗體來(lái)源:Rabbit 、Mouse 、Goat 、Rat、Sheep、Chicken、Hamster 、Guinea Pig 、Donkey、Human 、Armenian Hamster、Pig 、Escherichia Coli (E. coli) 、Duck等物種
本產(chǎn)品僅用于科研,不用于臨床
英文名稱 Anti-Ret/HSCR1
中文名稱 原癌基因酪氨酸蛋白激酶受體RET/多發(fā)性內(nèi)分泌腺瘤和甲狀腺髓樣癌蛋白抗體
別 名 C ret; Cadherin family member 12; CDHF 12; CDHF12; ELKS Fusion gene; HSCR 1; HSCR1; Hydroxyaryl protein kinase; MEN2A; MEN2B; MTC 1; MTC1; Multiple endocrine neoplasia and medullary thyroid carcinoma 1; Oncogene RET; Proto oncogene tyrosine protein kinase receptor ret; Proto-oncogene c-Ret; Proto-oncogene tyrosine-protein kinase receptor ret; PTC; RET; RET ELE1; Ret Proto oncogene; RET transforming sequence; RET_HUMAN; RET51.
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Cow, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 腫瘤 信號(hào)轉(zhuǎn)導(dǎo) 生長(zhǎng)因子和激素 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 124kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Ret/HSCR1
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed. [provided by RefSeq, Jul 2008].
宿主:Human、Murine、Rat (Rattus)、Bovine、Dog (Canine)等物種
原癌基因酪氨酸蛋白激酶受體RET/多發(fā)性內(nèi)分泌腺瘤和甲狀腺髓樣癌蛋白抗體應(yīng)用范圍: WB, ELISA, IP, IHC (p), IHC (f), IF
緩沖液:0.01m PBS,pH值7.4和10毫克/毫升BSA
儲(chǔ)存液:0.1%(w/v)*
Anti-B7-DC/PDL2/CD273程序性死亡配體2抗體Y580820.1ml
Anti-phospho-BAD磷酸化相關(guān)死亡促進(jìn)因子抗體Y580830.1ml
Anti-Batroxobin蛇毒巴曲酶抗體Y580840.1ml
Anti-Bax Bax(小鼠來(lái)源抗體)Y580850.1ml
Anti-Bcl-xLBcl-xL蛋白抗體Y580860.1ml
Anti-BBC3/PUMAp53正向細(xì)胞凋亡調(diào)控因子抗體Y580870.1ml
Anti-phospho-Bcl-xL抗磷酸化Bcl-xL(pSer62)蛋白抗體Y580880.1ml
Anti-BCHENT丁酰膽堿脂酶抗體(N端)Y580890.1ml
Anti-BCHE抗丁酰膽堿脂酶單克隆抗體Y580900.1ml
Anti-BCHECT丁酰膽堿脂酶抗體(C端)Y580910.1ml
Anti-BECN1一種抑癌基因抗體Y580920.1ml
Anti-Beta-caseinβ-酪蛋白(抗體)兔抗山羊、綿羊Y580930.1ml
Anti-BAFF/CD257TNF家族B細(xì)胞激活因子抗體Y580940.1ml
Anti-BIN1橋連整合因子蛋白抗體Y580950.1ml
Anti-Bim細(xì)胞死亡調(diào)解子抗體Y580960.1ml
Anti-BMP4骨形態(tài)發(fā)生蛋白4抗體Y580970.1ml
Anti-BMPR-1A骨成型蛋白受體1A抗體Y580980.1ml
Anti-BNP腦鈉素/利鈉肽抗體 Y580990.1ml
Anti-B RafB Raf抗體Y581000.1ml
Anti-BRCA1乳腺癌易感基因1抗體(人)Y581010.1ml
Anti-BrdU溴脫氧尿苷單克隆抗體Y581020.1ml